PDMI hier steht der nächste rebound an - 500 Beiträge pro Seite

[Toth]

guckt euch den chart an, hier sollte es die nächten tage gut up/ab gehen. pdmi ist total überverkauft!





dazu gab es gestern gegen handelsschluss diese nette pr

April 21, 2009 - 1:16 PM EDT


Paradigm Medical Industries Expands Its US and Global Reach With New Sales Force
Paradigm Medical Industries Expands Its US and Global Reach With New Sales Force

SALT LAKE CITY, UT -- (Marketwire) -- 04/21/09 -- Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced today that the Company is expanding its domestic and international reach with the addition of ten new independent sales representatives in the United States. In addition, the company plans to add fifteen new international distributors by the middle of this year. Paradigm Medical also expects to add an additional ten to fifteen new domestic sales representatives, selectively placed throughout the domestic market, by the beginning of the third quarter of 2009. This aggressive expansion of the Company's sales force is to meet the demand that will be created through new product releases, current unique products and new partnerships with other ophthalmic organizations.

"I am delighted to have assembled this dynamic and enthusiastic sales team, a much needed component to our success," said Paradigm Medical President Stephen Davis. "With a focus on providing our customers with critical insight to upcoming new and innovative products, our team will play a vital role in establishing relationships with existing and new clients. I am looking forward to working closely with them." Stephen Davis continues, "The U.S. ophthalmic diagnostic device market is a $250 million market and we intend to utilize the sales force so that we may not only grow our share of the market but also to expand the size of the market through new proprietary products and technology."

About Paradigm Medical Industries, Inc.

Headquartered in Salt Lake City, UT, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

For more information, please visit: www.paradigm-medical.com

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Contact:
Paradigm Medical Industries, Inc.
Stephen Davis
President
801-977-8970
www.paradigm-medical.com

viel spaà beim traden
mfg
toth

[Toth]

rt-chart

[Toth]

das sieht ja mehr als gut aus, mal schauen ob es gleich durch die 0,003 geht.

[Toth]

na das war wohl noch nix mit der 003. jetzt kann man nochmal schön ein paar shares bei 002-0022 abgreifen, spätestens morgen sollte die 003 doch fallen der chart hat ja gerade erst gedreht. bin mal gespannt wo wir heute schließen.

[egon-olsen]

Luftnummer

[Toth]

Antwort auf Beitrag Nr.: 37.020.725 von egon-olsen am 22.04.09 20:02:15

warte es ab. ich denke das es hier die tage mindestens bis 004 geht. natürlich ist es ein otc-wert, play the stock and not the story. ich fahre immer gut damit und mache ein paar schnelle 100%. wer die letzten male auf mich gehört hat konnte diese auch mitnehmen. also wo ist da das problem?

mfg
toth

[Toth]

morgen

sk 0,0021 + 40%

bid 0,0021
ask 0,0023

[Toth]

die mm haben den ask schonmal auf 0025 hoch getaxt.

[Dr.Spezialist]

Darauf gib mal lieber nix!

Aber das Produkt und der Preis scheinen gut.

Qualität hat nix mit Quickie zu tun

[infight]

[Dr.Spezialist]

Bin noch da

irgendwas stimmt mich immer positiver.
Immerhin gibt es die Aktie noch.

[Illuminat85]

geht bald los, alles festhalten!

[Illuminat85]

Antwort auf Beitrag Nr.: 37.258.593 von Illuminat85 am 27.05.09 00:00:00

sehe gerade:

Beitrag Nr.: 37.258.593im neuen Fenster öffnen von Illuminat85 am 27.05.09 00:00:00

also wenn das kein gutes zeichen ist

[Illuminat85]

NEWS

Paradigm Medical Announces Plans to Release Its New Corneal Topographer, the Paravue, in the United States Market

SALT LAKE CITY, UT -- (Marketwire) -- 06/01/09 -- Paradigm Medical Industries, Inc.

(OTCBB: PDMI) announced today that the Company will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. The Paravue is a sophisticated topographer utilizing Placido Disk Technology and an advanced software to provide accurate and detailed analysis of the anterior corneal surface.

Corneal topography -- also known as videokeratography or corneal mapping -- represents a significant advance in the measurement of the corneal curvature. Most corneal topographers evaluate 8,000 to 10,000 specific points across the entire corneal surface. By contrast, the Paravue processes more than 100,000 points. It also offers corneal wave front analysis with 2, 3 or 4 maps available for comparison.

The Paravue provides both a qualitative and quantitative evaluation of corneal curvature. It does so by utilizing a big placido disk with 24 concentric rings, which project onto the cornea to create a virtual image.

The device compares this image to the target size, and the computer then calculates the corneal curvature. Advanced features including advanced rings editing, variable scales, refractive power map and more make the Paravue a valuable tool in the optometric and ophthalmic clinics.

"The addition of the Paravue to our existing ophthalmic product line fills an important segment that was missing," said Paradigm Medical President, Stephen Davis. "We are excited to offer not just another topographer, but one with many impressive features and incredibly friendly software that provides ease of use, flexible mapping and accuracy."

About Paradigm Medical Industries, Inc.

Headquartered in Salt Lake City, UT, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

For more information, please visit: www.paradigm-medical.com

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Contact:

Paradigm Medical Industries, Inc.

Stephen Davis

President

801-977-8970

www.paradigm-medical.com

[Dr.Spezialist]

Das Bauchkribbeln wird aber noch stärker, irgendwie ist das noch nicht alles.
Reines Gefühl , aber lassen wir uns mal überraschen

[stern16]

Antwort auf Beitrag Nr.: 37.311.868 von Dr.Spezialist am 03.06.09 16:36:02

Auffällig sind die zahlreichen Beiträge in den US- Foren zum Thema PM in letzter Zeit.

Hab mich nochmal gestern richtig eingedeckt, mal abwarten was passiert

[stern16]

Antwort auf Beitrag Nr.: 37.315.960 von stern16 am 04.06.09 06:02:17

SOURCE: Paradigm Medical Industries, Inc.

2009-06-01 07:30:00
Paradigm Medical Announces Plans to Release Its New Corneal Topographer, the Paravue, in the United States Market

SALT LAKE CITY, UT--(eMediaWorld - June 1, 2009) - Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced today that the Company will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. The Paravue is a sophisticated topographer utilizing Placido Disk Technology and an advanced software to provide accurate and detailed analysis of the anterior corneal surface.

Corneal topography -- also known as videokeratography or corneal mapping -- represents a significant advance in the measurement of the corneal curvature. Most corneal topographers evaluate 8,000 to 10,000 specific points across the entire corneal surface. By contrast, the Paravue processes more than 100,000 points. It also offers corneal wave front analysis with 2, 3 or 4 maps available for comparison.

The Paravue provides both a qualitative and quantitative evaluation of corneal curvature. It does so by utilizing a big placido disk with 24 concentric rings, which project onto the cornea to create a virtual image. The device compares this image to the target size, and the computer then calculates the corneal curvature. Advanced features including advanced rings editing, variable scales, refractive power map and more make the Paravue a valuable tool in the optometric and ophthalmic clinics.

"The addition of the Paravue to our existing ophthalmic product line fills an important segment that was missing," said Paradigm Medical President, Stephen Davis. "We are excited to offer not just another topographer, but one with many impressive features and incredibly friendly software that provides ease of use, flexible mapping and accuracy."

About Paradigm Medical Industries, Inc.

Headquartered in Salt Lake City, UT, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

For more information, please visit: www.paradigm-medical.com

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

[Illuminat85]

villeicht wirds ja diese woche was

[Dr.Spezialist]

Was geschieht denn da heute?
Weiß einer mehr?

[infight]

[Illuminat85]

so gefällt mir das

http://www.americanbulls.com/StockPage.asp?CompanyTicker=PDM…

[stern16]

Im Amiland ist PM gestern ganz gut abgegangen, mal schauen was heute passiert. Hier in Deutschland ist momentan absolut tote Hose angesagt.

Ich hab letzte Woche an der Börse in USA fett eingekauft, jetzt bereits 250 % im Plus.

Hoffe allen fette Beute, Gruß Stern16

[Dr.Spezialist]

Gratuliere zu 250 %
Die 0,004 muß aber noch genommen werden.

[Dr.Spezialist]

Wenn man aber den MK sieht , dann sage ich nur, eine Umsatz news kann diese Rakete gewaltig abschiessen.
Hoffen wir mal, dass sie endlich den verdienten Erfolg bekommen

[infight]

[infight]

[Dr.Spezialist]

Schon merkwürdig wie es wieder runtergeht. Denke viele sehen die Aktie nur als Zockeraktie.
Hier könnte aber mehr drinstecken

[GKN]

Erscheint mir gut für eine positive Überraschung zu sein

[GKN]

Achtung! Auf US-Kurs heute achten,da ist was positives im Busch

[infight]

Antwort auf Beitrag Nr.: 37.413.820 von GKN am 17.06.09 19:49:25

[infight]

charttechniker unter uns?

[infight]

enttäuschend.

[GKN]

Jetzt ist wohl wieder Zeit zum Einsteigen,die Unterstützung hat gehalten.Was fehlt,sind News.Potential zum Vervielfacher hat der Wert allemal

[GKN]

Liegt jetzt auf der Unterstützung,könnte bald was werden mit einem kräftigen Rebound,nur in den USA handeln versteht sich.

[infight]

bin auch wieder drin.

allerdings befürchte ich, dass sie massig neue aktien rausschmeissen werden.

[GKN]

Die 0,0020 sollten bald wieder zu schaffen sein,wäre schon mal ein Verdoppler von heute aus

[infight]

Antwort auf Beitrag Nr.: 37.645.575 von GKN am 25.07.09 12:03:53

aus welchem grund?

möchte jetzt mal die einnahmen sehn.

angeblich verkaufen sie ja ihre produkte.

[infight]

[GKN]

Die 0,0010 sind eine starke Unterstütung. Wichtig wäre grösseres Volumen oder noch besser News und die werden sicherlich kommen,bin bei dem Wert eher optimistisch.

[infight]

guter tag heute.

[BlackRifleHunter]

ich denke mal die läuft wieder 1-3 Tage

[GKN]

Jetzt gehts los,nächster Halt 0,0020!

[GKN]

Antwort auf Beitrag Nr.: 37.671.498 von GKN am 29.07.09 17:48:52

Persönliches Kursziel ist erreicht,vieleicht gehts aber noch weiter.

[infight]

ich bin raus.

vielleicht steig ich nochmal ein.

[muetze0072]

gibt es irgendwas neues zu berichten? gehandelt wird ja wohl nicht mehr. danke

[stern16]

Weiß irgend jemand wie bzw. wo PDMI handelbar ist, nachdem die Aktien in die Pink- Sheets abgestuft worden sind? Bei meiner Bank sind sämtliche Anteile gesperrt bzw. nicht handelbar.
Ist eine Wiedereinstufung in die OTC wieder denkbar?

Falls irgendjemand Info hat wäre ich dankbar.

MfG Stern16

[Dr.Spezialist]

Da geht was , die geht ab.
Große Umsätze und mit kleinen wird gedeckelt. ..oder wie seht ihr das.

[Dr.Spezialist]

Oder sind wieder nur Zocker am Werk . Wo ist die Mitteilung.
Bin raus. OTC ist einfach zu heiss.

[caxis2009]

A Renewed Sense of Optimism in Paradigm Medical (OTC:PDMI.PK)

Print article
Refer to a friend


StocksHaven Investments
2009-10-13 11:03:03 - Paradigm Medical Rebounds as Investors Await Four New Devices (OTC:PDMI.PK)


The Medical device industry has been one of the most successful industries within 2008 and 2009, and 2010 should continue that trend. StocksHaven Investments profiles Paradigm Medical Industries, Inc. (OTC:PDMI.PK), a promising company who will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. Plagued by lawsuits, financial woes,
and poor management — the company has made a vast array of changes during late 2008 and 2009 leading to an invigorated interest in past and present shareholders. The company named Stephen Davis the new president, an individual with an impeccable ability to attain funds and grants for struggling institutions, alongside 20 years experience in the ophthalmic industry. Paradigm also has the only patented technology utilizing photon lasers for cataract removal and is poised to capture a niche market within the glaucoma and ultrasound microscopy fields. The glaucoma market alone is estimated to reach $4 billion in 2010. With a portfolio consisting of a total of 15 devices currently available, and 4 pending release with one expect by end of 2009, Paradigm seems to have positioned itself nicely for a rebound in the near future.

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. develops, manufactures, sources, markets and sells ophthalmic surgical and diagnostic instrumentation and related accessories, including disposable products. The Company’s surgical equipment is designed for minimally invasive cataract treatment. Its cataract removal system, the Photon laser system, is a laser cataract surgery system designed to be marketed as the next generation of cataract removal. The Company’s diagnostic products include a P2000 pachymetric analyzer, a P37 Ultrasonic A/B Scan, P40, P45 and P60 UBM Ultrasound Biomicroscopes, a P37 A/B Scan, two perimeters, the Blood Flow Analyzer, and the Glaid. The diagnostic ultrasonic products, including the P2000 pachymetric analyzer, the P37 Ultrasonic A/B Scan and the P40 UBM Ultrasound Biomicroscope were acquired from Humphrey Systems, a division of Carl Zeiss.

The full special report on the company appears today at www.stockshaven.com/a-renewed-sense-of-optimism-in-paradigm-medi ..

Disclosure: Short-term position in PDMI

To feature your publicly traded company in StocksHaven.com Alerts or as a fully profiled company, email us at [e-mail] or visit www.stockshaven.com/ir_contract/ for more info

###

About StocksHaven Investments

StocksHaven Investments can be found at StocksHaven.com. It is a company offering a news portal covering the world financial news and equities sector. It features its own blog, free level 2 quotes, two way linking capability, mass e-mail distribution alerts, stock research reports, conference calls, news feeds, mailing list, videos, press release capability, stock commentaries, company reviews and other unique content including expert stock analysis from Michael Vlaicu. The company also offers Investor Relations contracting services.

For more financial and investment news, visit www.StocksHaven.com

Certain sections of this report contain forward-looking statements that are based on our reporters' expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements, which include but are not limited to projections of revenues, earnings, segment performance, cash flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors including but not limited to the status or outcome of legal and/or regulatory proceedings.

All forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. All subsequent written and oral forward-looking statements attributable to the company or any person acting on the company's behalf are qualified by the cautionary statements in this section. StocksHaven.Com does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.


Contact Information:
StocksHaven Investments



Contact Person:
Michael Vlaicu
Founder, Lead Investment Analyst
email: email

Web: www.StocksHaven.com

--------------------------------------------------------------------------------



Author:
Michael Vlaicu
e-mail
Web: www.stockshaven.com
Phone: [phone]

Quelle: http://www.pr-inside.com/a-renewed-sense-of-optimism-in-r152…

[caxis2009]

Was für eon Volumen und es geht weiter $$

[caxis2009]

Ticker-Symbol ist PDMI

[caxis2009]

http://investorshub.advfn.com/boards/board.aspx?board_id=446…

[caxis2009]

PDMI FDA Approved Devices/Products...

Below are the "four" Paradigm Medical Industries, Inc. (PDMI) FDA Approved Devices/Products that are currently listed within the official FDA website:

http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[caxis2009]

well heres your chance..PDMI

how many thought they were smart selling ASFX and BIEL at .003's and then moved on.. then saw the runs and puked at the missed gains..

lots of shares traded over .004...mm's just shook out flippers end of day...

next level should be .007's to .008 as the first serious assault at .01's

[caxis2009]

Next Monster - Volumen $$

[Ventrikel]

Antwort auf Beitrag Nr.: 38.171.602 von caxis2009 am 14.10.09 04:24:44

Bin eigentlich nur wegen dem neuen CEO vor Monaten mit 2 Mill Shares relativ tief eingestiegen.
Sie läuft, sicher auch mediengesteuert.
Insgesamt aber eine völlig unterbewertete Aktie mit enormem Potential, ne bahnbrechende News wäre bald wichtig, z. B. daß GE oder Bausch-Lomb sich interessieren oder Aktien gekauft haben.
Vielleicht laufen aber auch schon derartige Gespräche, Finanzierung, Merger usw.
Auf alle Fälle ein Invest, daß ein bißchen Geduld erfordert.

Mfg Vent

[stern16]

Leider sind sind meine Anteile auf einem Depot bei der Comdirekt und darum leider nicht handelbar, da PM in die Pink Sheets abgestiegen ist.
Kann mir jemand eine Rat geben, wie ich die guten Stücke wieder handeln kann?

[caxis2009]

Antwort auf Beitrag Nr.: 38.173.606 von Ventrikel am 14.10.09 11:50:30

Sehe vollkommen genauso.Aber es wird sich sicherauszahlen $$, davon bin Ich persöhnlich fest überzeugt $$

caxis

[caxis2009]

Antwort auf Beitrag Nr.: 38.173.738 von stern16 am 14.10.09 12:02:31

Erstmal Willkommen an Alle und grüß euch.Hier wird es demnächst krachen, aber gewaltig $$$$


Hallo ster16,m Du kannst die PDMI nur in den USA KAUFEN, Ticker - Symbol ist PDMI

caxis

[Leele]

nanu!!! was riech ich denn hier??

warum startet PDMI so plötzlich durch??

[Leele]

ah... oki

na denn

[Leele]

oki bin drin

was glaubt ihr wohin die reise gehen wird?

ehrlich ich hab noch keine so rechte ahnung wo ich drin bin. hab mich nur spontan dazu entschieden. ist sonst nicht meine sache aber bei dem zock... besteht die möglichkeit 1cent zuknacken???

gruß leele

[papschy]

Antwort auf Beitrag Nr.: 38.176.541 von Leele am 14.10.09 16:19:38

Hallo zusammen

Genau habe auch keinen blassen schimmer wo ich hier aufgesprungen bin aber es schaut echt gut aus

[cjr]

Antwort auf Beitrag Nr.: 38.177.569 von papschy am 14.10.09 17:55:39

mal wieder ein geiler zock

am Freitag gekauft und schon 200%...

Mein Einstieg hab ich erstmal rausgezogen...

aber denk die läuft noch ein bissle

[caxis2009]

PDMI - MOSTER wir weiter steigen

In den folgende Seiten habe Ich für einige Informationen.

PDMI ist persöhnlich gesehen meine Lieblings - Harcore Aktie $$

Im Vorwege erstmal willkommensgruß an cjr,Leele,Papschy uns Konsorten und an Alle.

[caxis2009]

Posted by: mkt_predictor Date: Friday, October 09, 2009 1:02:07 AM
In reply to: None Post # of 8716

Posted by: $heff Date: Friday, October 09, 2009 12:52:47 AM
In reply to: $heff who wrote msg# 17409 Post # of 17442

SHEFF DD Alert (Post #2 of 2) PDMI at .0015 on 10/8/09. PDMI is significantly undervalued compared to other companies in its space. Could easily be a .03 to .05 cent stock based on potential and what the company has in the pipeline. PDMI time is now in the 4th Quarter of 2009. PDMI could be a significant buyout target for big Pharma (Alcon or Bausch & Lomb). Key Forward Looking Events for PDMI are 1) They have Multiple ophthalmic products, 2) 1 pending FDA decision per 10Q (Sales of surgical products are at a standstill pending FDA approval of the Photon TM laser system), and 3) CPT-11 code for reimbursement (“ The Blood Flow Analyzer™ is expected to have a new CPT reimbursement code for Medicare insurance providers issued before the end of 2009”). 4) A big boon for the company is that Paradigm Medical has announced plans to Release Its New Corneal Topographer, the Paravue, in the United States Market! That will occur in the 4th quarter.

52 wk high is ..055 & 52 wk low is .0009. Closer to the low than high and this has much more potential than 1 yr ago!

MEDICAL RUNNERS IN 2009
BIEL.PK from .0013 in May to .12 in September w/ Caveat Emptor on pink sheets. 1.5 bill auth and o/s is that was almost maxed. PDMI is fully-reporting on the pink sheets!

ASFX.PK from .002 in August to .08 in September
NEPH.OB from .06 in April to $2.40 in September 09
NPHC.OB from .05 in August to $1.00 in September 09
PWRM.OB from .014 in August to .15 in September 09
IMGG from .05 in August to .54 in September
XCHO from .012 in August to .17 in September
LLBO.PK from .0018 to .018 in August w/5 bill auth shares and o/s almost maxed out w/ only 1 product.


3 FORWARD LOOKING EVENTS THAT COULD PROPEL THE PRICE OF PDMI
1) FDA Clearance
2) CPT Reimursement Code for Medicare in 4th Qrtr of 2009
http://ophthalmologytimes.modernmedicine.com/ophthalmologyti…
3) Paravue will be introduced the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009

PATENTED PRODUCTS- Laser surgical handpiece with photon trap
Headquartered in Salt Lake City, UT , Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States , as well as internationally.
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=H…

Paradigm Medical Poised to Expand Stake in $250-Million U.S. Ophthalmic Diagnostic Device Market
http://ih.advfn.com/p.php?pid=nmona&cb=1239323369&article=34…

Recent runners- LLBO recently ran from .001 to .018 on news that they were going to file for their First Warning Breast Cancer Detection. They have 5 billion A/S and actively dilute shares to obtain cash for the company. They are currently about (.005) cents right now. PWRM ran from .018 to .15 in two weeks on clinical markers for Alzheimer’s Disease and Breast Cancer. NPHC recently went from .05 to .95 based on a product not even available yet but with a lot of potential! They also have a much larger share structure. MEDICAL COMPANIES ARE BLAZING HOT in this Medical Enviroment now.
PDMI is not on the radar and should be with the significant events that are forthcoming in this 4th quarter based on their 10Q as the quarter just started on Oct 1st.

Share Structure (From Latest 10Q period ending 3/31/09)
Auth 1.4 Billion
O/S 519,251, 922
Float
Recent 8-k
The Company's Board of Directors made this decision to voluntarily deregister the Company's common stock based on several factors, including the costs of preparing and filing periodic reports with the SEC, and the elimination of the substantial legal, audit, and other costs associated with being a reporting company. The Board of Directors determined that the increasing financial costs and commitment of management's time to ongoing SEC reporting and complying with the many new regulations that have been adopted is not justified in the Company's circumstances. The Board of Directors believes that freeing up these resources will create value for the Company's shareholders by allowing management to better prepare and execute strategic plans, and improve the Company's long-term financial strength.
http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=67419…
Clinical studies on Photo will result from saving Photon Laser System and new inline products like Paravue will benefit significantly from savings the company will have. BIEL did the same thing with the Actipatch when cash was running low. They missed their filing and went into (CE) Caveat Emptor Status until last week where they are now fully reporting. There stock went from .0013 in May to .12 in Sept 09. PDMI is still reporting on the pink sheets.
Paradigm Medical Announces Plans to Release Its New Corneal Topographer, the Paravue, in the United States Market
Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced today that the Company will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. The Paravue is a sophisticated topographer utilizing Placido Disk Technology and an advanced software to provide accurate and detailed analysis of the anterior corneal surface.
Market Wire, June, 2009 http://findarticles.com/p/articles/mi_pwwi/is_200906/ai_n319…

PDMI: 2000-2008 Synopsis of Defense Contracts

Paradigm Medical Industries
Defense Contracts Awarded from 2000-2008
Total: 3
Amount: $88,880

Reference: http://www.governmentcontractswon.com/department/defense/par…

Paradigm Medical Industries
Julio Maximo
Vice President of Operations
[phone] ext. 643

On June 1st, Paradigm announced plans to release the first of four new ophthalmic diagnostic devices, the Paravue, in the United States. The sophisticated corneal topographer utilizes Placido Disk Technology and advanced software to provide an accurate and detailed analysis of the anterior corneal surface, making it a valuable addition to optometric and ophthalmic clinics.
Last month, Paradigm also announced plans to begin clinical work to upgrade its Blood Flow Analyzer device from an Investigational to a Reimbursable level. The move could dramatically improve the device’s marketability as patients could be reimbursed by regional medical insurance companies for testing using the Blood Flow Analyzer.


We specialize in the development and marketing of diagnostic equipment for the ophthalmic market. Our product families of topographers, autoperimeters and ultrasonic biomicroscopes combined withour unique Blood Flow Analyzer help the eye care professionals community diagnose and treat disorders of the eye such as glaucoma, cataracts and age-related macular degeneration.

Sales of the P60 UBM Ultrasound Biomicroscope increased by $68,000 to $73,000, or 44% of total revenues, for the three months ended March 31, 2009, compared to $5,000, or 2% of total revenues, for the same period in 2007. Sales of the Blood Flow Analyzer™ increased by $11,000 to 14,000 or 9% for the three months ended March 31, 2009, compared to net sales of $3,000, or 1% of total revenues, during the same period in 2008. Sales from the P2700, P37, and P37-II A/B Scan Ocular Ultrasound Diagnostic devices decreased by $34,000 to $7,000, or 5% of total revenues for the three months ended March 31, 2009, compared to $41,000, or 18% of total revenues for the same period in 2008. Sales of the P55, P2200, P2500 Pachymetric Analyzers, and the P2000 A-Scan Biometric Ultrasound Analyzer decreased by $7,000 to $0 or 0% of total revenues, for the three month period ended March 31, 2009, compared to $7,000, or 3% of total revenues, for the same period in 2008. Combined sales of the LD 400, TKS 5000, and CT200 Autoperimetry Systems decreased by $97,000 to $33,000, or 22% of the total revenues, for the three months ended March 31, 2009, compared to $130,000, or 57% of total revenues, for the same period in 2008.

Sales of the Blood Flow Analyzer TM decreased due in part from the reorganization of the Company's sales force. The Company anticipates continuing the upward trend in Blood Flow Analyzer TM sales through additional efforts by the Company to gain more wide spread support from the Blood Flow Analyzer TM through increased clinical awareness, product development and improved marketing plans.

Sales of surgical products are at a standstill pending FDA approval of the Photon TM laser system. In the twelve month period ended December 31, 2008, the Company realized no sales in the surgical line consisting of the Photon TM laser system. There were also no sales in the surgical line for the comparable period of 2007.

The Company anticipates reversing the downward trend in sales through additional efforts by the Company to gain more widespread support for the P60 UBM Ultrasound Biomicroscope, the Blood Flow Analyzer™, the LD400 Antoperimetry System, the P37-II Ocular Ultrasound Diagnostic A/B Scan, the 2200 and 2500 Pachymetric Analyzers, the P2000 A-Scan Biometric Ultrasound Analyzer, the new agreement with the Costrugione Srumenti Oftalmici ("CSO") organization and its ophthalmic products, and through increased clinical awareness, ongoing product development, improved marketing plans and strategic product replacement, and ongoing development of the LD400 perimeter. The Blood Flow Analyzer™ is expected to have a new CPT reimbursement code for Medicare insurance providers issued by the end of 2009, reversing the downward sales trend it has experienced.


This company will move higher based on potential and the cost of its medical devices. This company is in poor financial situation and owes convertible debts to 4 accredited investors. It is a pink sheet with significant potential that can change its fortune overnight with an FDA Decision or if any or all of the forward-looking statements come true. This is a definite diamond in the rough just like other medical companies that I have discussed in this post.

FULL DISCLOSURE IN LINKS BELOW!
http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[caxis2009]

PDMI FDA Approved Devices/Products...

Below are the "four" Paradigm Medical Industries, Inc. (PDMI) FDA Approved Devices/Products that are currently listed within the official FDA website:


http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[caxis2009]

Posted by: stervc Date: Tuesday, October 13, 2009 8:27:10 PM
In reply to: None Post # of 8719

Awesome PDMI Article & Audio DD..

Within the link below, click the "listen now" button and listen as you scroll down the page to review PDMI info and their devices:


http://www.stockshaven.com/a-renewed-sense-of-optimism-in-pa…

v/r
Sterling

[caxis2009]

PDMI = Monster - Ja Das stimmt $$

[caxis2009]

PDMI L2 - Von heute Abend

http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[caxis2009]

A Renewed Sense of Optimism in Paradigm Medical (OTC:PDMI.PK)

Print article
Refer to a friend


StocksHaven Investments
2009-10-13 11:03:03 - Paradigm Medical Rebounds as Investors Await Four New Devices (OTC:PDMI.PK)


The Medical device industry has been one of the most successful industries within 2008 and 2009, and 2010 should continue that trend. StocksHaven Investments profiles Paradigm Medical Industries, Inc. (OTC:PDMI.PK), a promising company who will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. Plagued by lawsuits, financial woes,
and poor management — the company has made a vast array of changes during late 2008 and 2009 leading to an invigorated interest in past and present shareholders. The company named Stephen Davis the new president, an individual with an impeccable ability to attain funds and grants for struggling institutions, alongside 20 years experience in the ophthalmic industry. Paradigm also has the only patented technology utilizing photon lasers for cataract removal and is poised to capture a niche market within the glaucoma and ultrasound microscopy fields. The glaucoma market alone is estimated to reach $4 billion in 2010. With a portfolio consisting of a total of 15 devices currently available, and 4 pending release with one expect by end of 2009, Paradigm seems to have positioned itself nicely for a rebound in the near future.

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. develops, manufactures, sources, markets and sells ophthalmic surgical and diagnostic instrumentation and related accessories, including disposable products. The Company’s surgical equipment is designed for minimally invasive cataract treatment. Its cataract removal system, the Photon laser system, is a laser cataract surgery system designed to be marketed as the next generation of cataract removal. The Company’s diagnostic products include a P2000 pachymetric analyzer, a P37 Ultrasonic A/B Scan, P40, P45 and P60 UBM Ultrasound Biomicroscopes, a P37 A/B Scan, two perimeters, the Blood Flow Analyzer, and the Glaid. The diagnostic ultrasonic products, including the P2000 pachymetric analyzer, the P37 Ultrasonic A/B Scan and the P40 UBM Ultrasound Biomicroscope were acquired from Humphrey Systems, a division of Carl Zeiss.

The full special report on the company appears today at http://www.stockshaven.com/a-renewed-sense-of-optimism-in-pa… ..

Disclosure: Short-term position in PDMI

To feature your publicly traded company in StocksHaven.com Alerts or as a fully profiled company, email us at [e-mail] or visit http://www.stockshaven.com/ir_contract/ for more info

###

About StocksHaven Investments

StocksHaven Investments can be found at StocksHaven.com. It is a company offering a news portal covering the world financial news and equities sector. It features its own blog, free level 2 quotes, two way linking capability, mass e-mail distribution alerts, stock research reports, conference calls, news feeds, mailing list, videos, press release capability, stock commentaries, company reviews and other unique content including expert stock analysis from Michael Vlaicu. The company also offers Investor Relations contracting services.

For more financial and investment news, visit http://www.StocksHaven.com

Certain sections of this report contain forward-looking statements that are based on our reporters' expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements, which include but are not limited to projections of revenues, earnings, segment performance, cash flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors including but not limited to the status or outcome of legal and/or regulatory proceedings.

All forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. All subsequent written and oral forward-looking statements attributable to the company or any person acting on the company's behalf are qualified by the cautionary statements in this section. StocksHaven.Com does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.


Contact Information:
StocksHaven Investments



Contact Person:
Michael Vlaicu
Founder, Lead Investment Analyst
email: email

Web: http://www.StocksHaven.com

[caxis2009]

http://www.live-pr.com/en/for-new-medical-devices-coming-for…" target="_blank" rel="nofollow ugc noopener">http://www.live-pr.com/en/for-new-medical-devices-coming-for…

[caxis2009]

A Renewed Sense of Optimism in Paradigm Medical (OTC:PDMI.PK)
For New Medical Devices Coming for Paradigm Medical (OTC:PDMI.PK)


StocksHaven Investments

13.10.2009 11:33:04 Paradigm Medical Rebounds as Investors Await Four New Devices (OTC:PDMI.PK)

(live-PR.com) - The Medical device industry has been one of the most successful industries within 2008 and 2009, and 2010 should continue that trend. StocksHaven Investments profiles Paradigm Medical Industries, Inc. (OTC:PDMI.PK), a promising company who will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. Plagued by lawsuits, financial woes,




and poor management — the company has made a vast array of changes during late 2008 and 2009 leading to an invigorated interest in past and present shareholders. The company named Stephen Davis the new president, an individual with an impeccable ability to attain funds and grants for struggling institutions, alongside 20 years experience in the ophthalmic industry. Paradigm also has the only patented technology utilizing photon lasers for cataract removal and is poised to capture a niche market within the glaucoma and ultrasound microscopy fields. The glaucoma market alone is estimated to reach $4 billion in 2010. With a portfolio consisting of a total of 15 devices currently available, and 4 pending release with one expect by end of 2009, Paradigm seems to have positioned itself nicely for a rebound in the near future.

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. develops, manufactures, sources, markets and sells ophthalmic surgical and diagnostic instrumentation and related accessories, including disposable products. The Company’s surgical equipment is designed for minimally invasive cataract treatment. Its cataract removal system, the Photon laser system, is a laser cataract surgery system designed to be marketed as the next generation of cataract removal. The Company’s diagnostic products include a P2000 pachymetric analyzer, a P37 Ultrasonic A/B Scan, P40, P45 and P60 UBM Ultrasound Biomicroscopes, a P37 A/B Scan, two perimeters, the Blood Flow Analyzer, and the Glaid. The diagnostic ultrasonic products, including the P2000 pachymetric analyzer, the P37 Ultrasonic A/B Scan and the P40 UBM Ultrasound Biomicroscope were acquired from Humphrey Systems, a division of Carl Zeiss.

The full special report on the company appears today at http://www.stockshaven.com/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/" target="_blank" rel="nofollow ugc noopener">http://www.stockshaven.com/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/

Disclosure: Short-term position in PDMI

To feature your publicly traded company in StocksHaven.com Alerts or as a fully profiled company, email us at [e-mail] or visit http://www.stockshaven.com/ir_contract/" target="_blank" rel="nofollow ugc noopener">http://www.stockshaven.com/ir_contract/ for more info

###

About StocksHaven Investments

StocksHaven Investments can be found at StocksHaven.com. It is a company offering a news portal covering the world financial news and equities sector. It features its own blog, free level 2 quotes, two way linking capability, mass e-mail distribution alerts, stock research reports, conference calls, news feeds, mailing list, videos, press release capability, stock commentaries, company reviews and other unique content including expert stock analysis from Michael Vlaicu. The company also offers Investor Relations contracting services.

For more financial and investment news, visit www.StocksHaven.com

Certain sections of this report contain forward-looking statements that are based on our reporters' expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements, which include but are not limited to projections of revenues, earnings, segment performance, cash flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors including but not limited to the status or outcome of legal and/or regulatory proceedings.

All forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. All subsequent written and oral forward-looking statements attributable to the company or any person acting on the company's behalf are qualified by the cautionary statements in this section. StocksHaven.Com does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.


Contact information:
StocksHaven Investments



Contact Person:
Michael Vlaicu
Founder, Lead Investment Analyst
Web: http://www.StocksHaven.com

Author:
Michael Vlaicu
e-mail
Web: http://www.stockshaven.com

[caxis2009]

I'm so glad OTCBlaze.com Alerted me this morning. I got in at .0038. This thing is gonna be a MONSTA! Here's the content from their alert:

October 14, 2009 Alert

Hello OTCBlaze Members,

We would like to announce the alert of Paradigm Medical Industries, Inc. (PDMI), which is currently at .0035. This company has had many challenges in the past; however, this trend could be turning. The pps recently moved from its 52-week low and the stock is starting get some major attention. The volume on 10/13/09 was huge, 515,874,437. We would love to see PDMI follow some of the other medical runners we've seen this year. Below are some examples:

1) BIEL.PK from .0013 in May to .12 in September
2) ASFX.PK from .002 in August to .08 in September
3) NEPH.OB from .06 in April to $2.40 in September
4) NPHC.OB from .05 in August to $1.00 in September
5) PWRM.OB from .014 in August to .15 in September
6) IMGG from .05 in August to .54 in September
7) XCHO from .012 in August to .17 in September
8) LLBO.PK from .0018 to .018 in August

Many of the above companies have less products and a greater float.

If any of the following future events take place, they could have a profound impact on the pps:

1) FDA Clearance
2) CPT Reimursement Code for Medicare in 4th Qrtr of 2009
3) Paravue will be introduced the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009.

Even with the excellent momentum of the stock, It's possible we'll see a small dip (hopefully not) very early, in preparation for the next leg up.

About Paradigm Medical Industries, Inc:

Paradigm Medical Industries, Inc. develops, manufactures, sources, markets and sells ophthalmic surgical and diagnostic instrumentation and related accessories, including disposable products. The Company's surgical equipment is designed for minimally invasive cataract treatment. Its cataract removal system, the Photon laser system, is a laser cataract surgery system designed to be marketed as the next generation of cataract removal. The Company's diagnostic products include a P2000 pachymetric analyzer, a P37 Ultrasonic A/B Scan, P40, P45 and P60 UBM Ultrasound Biomicroscopes, a P37 A/B Scan, two perimeters, the Blood Flow Analyzer, and the Glaid. The diagnostic ultrasonic products, including the P2000 pachymetric analyzer, the P37 Ultrasonic A/B Scan and the P40 UBM Ultrasound Biomicroscope were acquired from Humphrey Systems, a division of Carl Zeiss.
Additional information can be found here:

http://www.paradigm-medical.com/web/index.php

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=pdmi

We recommend you start doing research on this company and their stock. Please read our disclaimer in full and best of luck to you with your investment decisions.

[caxis2009]

http://www.reuters.com/article/pressRelease/idUS140140+07-Ap…

[caxis2009]

Paradigm Medical Industries Announces New President, Stephen Davis
Tue Apr 7, 2009 10:44am EDT Email | Print | Share| Reprints | Single Page[-] Text [+]

Featured Broker sponsored link
SALT LAKE CITY, UT, Apr 07 (MARKET WIRE) --
Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced today that
Stephen Davis, a leading executive in the medical device industry, has
been named new President of the Company. His range of sales, marketing,
manufacturing, and operations management in both the domestic and
international markets will prove very beneficial to the organization.

Mr. Davis brings over 25 years of experience in global healthcare and
medical devices markets and over 14 of those in the ophthalmic arena to
Paradigm Medical Industries, Inc. Stephen has also served as the President
and CEO for Zinetics Medical, Inc. Salt Lake City, Utah for nine years.
Stephen was successful in raising over $2.7 million for Zinetics Medical
and spearheaded the purchase of Zinetics Medical by Medtronic for over $50
million. He served as Site Director for Medtronic Functional Diagnostics
for a year after the conclusion of the sale of Zinetics Medical. Prior to
those responsibilities, Stephen was the Western Area Director for
Barnes-Hind Hydrocurve and held additional responsibilities as a Regional
Vice-President and District Sales Manager. He possesses a stellar
background in the areas of strategic planning, start-up ventures, P&L and
has a successful record in developing business in preparation for
acquisition. Mr. Davis also has an extensive knowledge of the
International markets. Stephen has a B.S. from Brigham Young University
and additional studies in International Business and Finance.

"I am delighted to take on the leadership role as Paradigm's new
President. The reorganization was the first step to making the Company
more attractive to a much broader base of investors," said Stephen Davis.
"We are in a better position for vertical growth as we re-launch our
marketing strategy globally which will also include focusing our
marketing efforts in North America on a much larger scale."

Paradigm Medical Industries, Inc. is a medical device company that
develops, manufactures and distributes cutting edge, new innovative
products in the diagnostic ultrasound and early glaucoma detection
markets. Paradigm has the only patented technology utilizing photon laser
for cataract removal. The Company is poised to capture a niche market
within the Glaucoma and ultrasound microscopy fields. Paradigm Medical
Industries markets its products to ophthalmologists, optometrists,
universities, and clinics throughout the United States, as well as
internationally.

For more information, please visit: www.paradigm-medical.com

This press release contains statements that, if not verifiable historic
fact, may be viewed as forward-looking statements that could predict
future events and outcomes with respect to Paradigm and its business. The
predictions embodied in these statements will involve risk and
uncertainties and, accordingly, actual results may differ significantly
from the results discussed or implied in such forward-looking statements.



Contact:
Paradigm Medical Industries, Inc.
Stephen Davis
President
801-977-8970
www.paradigm-medical.com

Copyright 2009, Market Wire, All rights reserved.

[caxis2009]

OS...under 520M by all accounts: http://www.otcbb.com/profiles/pdmi.htm

[caxis2009]

Posted by: ClayTrader Date: Wednesday, October 14, 2009 5:07:48 PM
In reply to: None Post # of 8733

** PDMI Video Chart 10/1/09 **

Very nice looking chart... congrats to all those playing it... very encouraging to see how it has broken above that resistance trendline...

** Make $$$ + Free eBook ** - http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

Does Using Charts 'Actually' Work?? - http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

Need an annotated chart? - stop by my board - http://investorshub.advfn.com/boards/board.aspx?board_id=876…

Link to video - http://www.youtube.com/watch?v=0i51xIXHRhY

[caxis2009]

PDM;I = Monster , Ja , das stimmt $$ Die Reise geht weiter

[Leele]

meine güte

na da bin ich ja baff. die reise geht ja über einen cent!!!

www.paradigm-medical.com

[Leele]

meine güte

http://www.youtube.com/watch?v=0i51xIXHRhY

http://www.americanbulls.com/StockPage.asp?CompanyTicker=PDM…

weiterhalten. bis 0.007 freie fahrt danach 0.01!!!

[Leele]

danke caxis2009

super zusammenstellung. kann dich verstehen warum dies deine lieblingshardcore aktie ist

bis 0.01 werd ich mich ihr auch widmen. wenn ich richtig gesehen habe hat sie potential bis 0.015??? nicht schlecht bei dem monstervolumen.

[Leele]

gleich gehts weiter

[Leele]

yessssss!!!!

und sie läuft weiter. man ist das irre!!!!

[Kinkikatze]

Antwort auf Beitrag Nr.: 38.182.844 von Leele am 15.10.09 12:07:42

Leele und Caxis
habt ihr euch schon wieder verabschiedet?
oder lasst ihr laufen ?
bin seit gestern auch dabei.
Vielleicht haben wir Glück
K.K.

[gerdass]

ist ja noch sehr ruhig hier

[Kinkikatze]

SK $ o,oo5 genau auf der Unterstützungslinie aufgesetzt.

Wie es weitergeht ?
Sehen wir am Montag um 15.3o Uhr.

K.K.

[Leele]

ich bin ausgestiegen gewesen.

werde aber heute wieder einsteigen

[Kinkikatze]

http://www.youtube.com/watch?v=Hs9kbNRh3Y0&feature=player_em…

tiefer als o,oo35 sollte es nicht gehen.
Warten und sehen.
Gute Nacht
K.K.

[Leele]

so! aufgehts. kaufsignal gesetzt. jetzt gehts wieder flott nach oben. wunderbares W-performance

[Leele]

yippppieeee und ich bin drin

[Leele]

es geht wieder los

alle anzeichen stehen auf grün

[om628]

Wer hier einsteigt, muss echt einen an der Waffel haben...reiner Betrug das ganze!

Die Firma hat absolut nichts zu bieten!

Wenn das Teil nicht mehr handelbar ist, wird der nächste Re-Split vollzogen.
Gab es ja schon einige Male...

Das beste ist aber dieser Thread:
2 blinde Hansels als Alleinunterhalter...

[muetze0072]

hallo, was passiert mit den aktien, die man über die dt. börse gekauft hat und nun im depot schlummern und nicht mehr handelbar sind?
Kann da noch was passieren?
Vielen Dank!

[Leele]

Antwort auf Beitrag Nr.: 38.235.367 von om628 am 22.10.09 20:02:49

du bist ja n ganz schlauer

[waxweazle]

Antwort auf Beitrag Nr.: 38.241.996 von Leele am 23.10.09 16:40:03

kommt mal hier rein hat sicheiniges geän dert neue infos + update im neuen Threat

http://www.wallstreet-online.de/diskussion/1153882-1-10/pdmi…

grüsse
wax

[om628]

Antwort auf Beitrag Nr.: 38.241.996 von Leele am 23.10.09 16:40:03

Worauf du dich verlassen kannst!

Eure Dummpushversuche landen ja reihenweise im Treibsand...

Klasse Performance,
aber die "Helden" sind natürlich mit Gewinn raus.

[Leele]

Antwort auf Beitrag Nr.: 37.240.901 von infight am 24.05.09 14:31:59

http://www.stockta.com/cgi-bin/analysis.pl?symb=PDMI&num1=71…

tiefer geht die stochastik nimmer sehe ich als kurzes kaufsignal zum schönen zock



und grün ist sie ebenfalls!!!

[Stayc]

A Renewed Sense of Optimism in Paradigm Medical (OTC:PDMI.PK)
For New Medical Devices Coming for Paradigm Medical (OTC:PDMI.PK)

StocksHaven Investments

13.10.2009 11:33:04 Paradigm Medical Rebounds as Investors Await Four New Devices (OTC:PDMI.PK)

(live-PR.com) - The Medical device industry has been one of the most successful industries within 2008 and 2009, and 2010 should continue that trend. StocksHaven Investments profiles Paradigm Medical Industries, Inc. (OTC:PDMI.PK), a promising company who will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. Plagued by lawsuits, financial woes,

and poor management — the company has made a vast array of changes during late 2008 and 2009 leading to an invigorated interest in past and present shareholders. The company named Stephen Davis the new president, an individual with an impeccable ability to attain funds and grants for struggling institutions, alongside 20 years experience in the ophthalmic industry. Paradigm also has the only patented technology utilizing photon lasers for cataract removal and is poised to capture a niche market within the glaucoma and ultrasound microscopy fields. The glaucoma market alone is estimated to reach $4 billion in 2010. With a portfolio consisting of a total of 15 devices currently available, and 4 pending release with one expect by end of 2009, Paradigm seems to have positioned itself nicely for a rebound in the near future.

[Leele]

was heißt das???

[Leele]

http://www.americanbulls.com/StockPage.asp?CompanyTicker=PDM…

[Leele]

http://www.stockta.com/cgi-bin/analysis.pl?symb=PDMI&num1=71…

[Leele]

na da sind wir heute noch lange nicht am ende der fahnenstange. wenn ich richtig lese dann müssten wir den cent-bereich montag erreichen, wenns 2010 ans riesen geschäft geht....

und zu verkaufen wäre ja blödsinn bei den aussichten

[Leele]

wir bauen grad ein neues großes kaufsignal. wenn die 0.006 geknackt wird geht der weg steil nach oben. passiert aber heute bestimmt nicht mehr. es wird nur kräftig wieder eingesammelt

freu mich schon auf 2010. nur noch einen monat bis dahin dann läuten die gewinne hier

[Leele]

wow gap nach oben gerissen! es geht weiter aufwärts

[Leele]

bei eröffnung wieder gap nach oben gerissen und gleich wieder geschlossen der trend zeigt extrem nach oben

http://www.stockta.com/cgi-bin/analysis.pl?symb=PDMI&num1=71…

noch einen monat bis 2010 dann beginnt die 1000% rallystory

[Leele]

http://www.americanbulls.com/StockPage.asp?CompanyTicker=PDM…

immer schön halten

[stern16]

Antwort auf Beitrag Nr.: 38.487.484 von Leele am 01.12.09 16:29:03

Paradigm Medical Announces the Introduction of the Paravue 300 and Surveyor 500 at 2009 American Academy of Ophthalmology in San Francisco
Marketwire
December 15, 2009: 12:25 PM ET

Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced today that it introduced two new products at the annual American Academy of Ophthalmology Meeting in San Francisco from October 24-27, 2009. The new products consisted of the Paravue 300, a corneal topographer, and the Surveyor 500, a fully capable corneal topographer with a Scheimpflug technology rotating camera for the measurement of interior ocular structures in the anterior segment.

These are the first two products Paradigm is introducing from its Italian partner, Costruzione Strumenti Oftalmici (C.S.O.), with additional products scheduled for 2010. The Paravue 300 and Surveyor 500 fill a gap created by an earlier decision to discontinue manufacturing the CT 200 (corneal topographer), which was outdated.

"The AAO attendees response to the Paravue 300 and Surveyor 500 was very impressive and will serve as a springboard for Paradigm to continue to develop, locate and introduce new and innovative products to the ophthalmic marketplace," said Stephen Davis, Paradigm President and CEO.

Paradigm Medical also announced the relocation of its corporate office to 4273 South 590 West, Salt Lake City, Utah 84123. All phone numbers will remain the same. "This move will provide Paradigm with a more suitable facility that meets its current manufacturing and operational needs and reduces its overhead cost," said Mr. Davis.

About Paradigm Medical Industries, Inc.

Headquartered in Salt Lake City, Utah, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early glaucoma detection and other eye disorders. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

For more information, please visit: www.paradigm-medical.com

Contact:
Paradigm Medical Industries, Inc.
Stephen Davis
President and CEO
801-977-8970

[muetze0072]

hallo,

habe von den teilen noch einige im depot.
gibt es was neues oder passiert da noch was.

vielleicht hat jemand eine info.
danke!

[Kinkikatze]

hallo, alle schon aufgegeben.

Ich glaube PDMI lebt wieder, heute + 72%.
Werde sie weiter im Auge behalten.

Gruß und schönes WE
K.K.

[Kinkikatze]

hier der Grund für den Anstieg:

http://finance.yahoo.com/news/Paradigm-Medical-iw-2563302057…

K.K.

[muetze0072]

hat jemand irgendetwas neues gehört?

Danke!